8:07 AM ET
8-K
Capital Raise
Avalo Therapeutics Capital Raise
Avalo Therapeutics entered into an at-the-market (ATM) sales agreement with Jefferies LLC to establish a program for the potential issuance and sale of up to $200 million of common stock. Simultaneously, the company terminated its existing sales agreement with TD Securities (USA) LLC (formerly TD Cowen) that had been in place since June 2025.
- Counterparty
- Jefferies LLC